| Product dosage: 0.3mg | |||
|---|---|---|---|
| Package (num) | Per bottle | Price | Buy |
| 1 | $60.27 | $60.27 (0%) | 🛒 Add to cart |
| 2 | $50.22 | $120.54 $100.45 (17%) | 🛒 Add to cart |
| 3 | $43.53 | $180.81 $130.58 (28%) | 🛒 Add to cart |
| 4 | $42.69 | $241.08 $170.76 (29%) | 🛒 Add to cart |
| 5 | $40.18 | $301.34 $200.90 (33%) | 🛒 Add to cart |
| 6 | $38.51 | $361.61 $231.03 (36%) | 🛒 Add to cart |
| 7 | $37.31 | $421.88 $261.16 (38%) | 🛒 Add to cart |
| 8 | $36.41 | $482.15 $291.30 (40%) | 🛒 Add to cart |
| 9 | $34.60 | $542.42 $311.39 (43%) | 🛒 Add to cart |
| 10 | $33.15
Best per bottle | $602.69 $331.48 (45%) | 🛒 Add to cart |
Synonyms | |||
More info:
Bimatoprost Ophthalmic Solution for Effective Glaucoma Management
Bimatoprost ophthalmic solution is a prostaglandin analog specifically formulated to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. As a first-line therapeutic option, it works by increasing the outflow of aqueous humor, thereby providing consistent and significant IOP reduction. Its once-daily dosing regimen supports patient adherence, while its well-established efficacy profile makes it a cornerstone in modern glaucoma treatment protocols. This medication represents a critical tool in preserving visual field and preventing optic nerve damage in chronic ocular conditions.
Careprost: Clinically Proven Eyelash Growth Serum
Careprost is an ophthalmic solution containing the active ingredient Bimatoprost, originally developed to treat ocular hypertension and glaucoma. Its notable secondary effect—enhanced eyelash growth—led to its development as a topical treatment for hypotrichosis of the eyelashes, a condition characterized by inadequate or insufficient lashes. This prescription medication works by extending the anagen (growth) phase of the eyelash hair cycle, resulting in lashes that are longer, thicker, and darker. It is a well-researched, FDA-approved treatment that offers a medical-grade solution for individuals seeking significant and measurable improvements in lash appearance and density.
Lumigan: Effective Intraocular Pressure Reduction for Glaucoma
Lumigan (bimatoprost ophthalmic solution) 0.01% is a prostaglandin analogue prescription medication specifically formulated to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. As a first-line therapeutic option, it offers a well-tolerated mechanism of action that enhances uveoscleral outflow, providing consistent 24-hour IOP control with once-daily dosing. Its efficacy, safety profile, and convenient administration have established it as a cornerstone in the long-term management of these sight-threatening conditions.
Abana: Natural Cardiovascular Support for Optimal Heart Health
Abana is a clinically studied, natural supplement formulated to support cardiovascular wellness and maintain healthy cholesterol levels already within the normal range. Developed through extensive research in Ayurvedic medicine, this proprietary blend combines potent botanicals and minerals known for their cardioprotective properties. Abana works holistically to promote circulatory function, support lipid metabolism, and provide antioxidant protection against oxidative stress. Its multi-mechanism approach makes it an ideal choice for individuals seeking comprehensive cardiovascular maintenance through evidence-based natural medicine.
Abhigra: Advanced Relief for Chronic Inflammatory Conditions
Abhigra represents a significant advancement in targeted anti-inflammatory therapy, engineered for patients with persistent inflammatory disorders who have found inadequate relief from conventional treatments. Developed through rigorous clinical research, this prescription medication employs a sophisticated mechanism of action to modulate inflammatory pathways at the cellular level, offering a new standard in both efficacy and tolerability. Its precision-targeted formulation minimizes systemic exposure while maximizing therapeutic impact at affected sites, making it a preferred option among rheumatologists, gastroenterologists, and dermatologists specializing in autoimmune and chronic inflammatory diseases.
Abilify: Atypical Antipsychotic for Symptom Control and Stability
Abilify (aripiprazole) is an atypical antipsychotic medication approved for the treatment of several psychiatric conditions, including schizophrenia, bipolar disorder, and as an adjunctive treatment for major depressive disorder. It functions as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and as an antagonist at serotonin 5-HT2A receptors, which contributes to its unique efficacy and tolerability profile. This mechanism helps stabilize dopamine and serotonin activity in the brain, reducing symptoms such as hallucinations, delusions, and mood swings while minimizing certain side effects commonly associated with first-generation antipsychotics.
Acamprol: Clinically Proven Relief for Alcohol Dependence
Acamprol (acamprosate calcium) is a prescription medication specifically developed to support maintenance of abstinence in alcohol-dependent patients. It functions by modulating neurotransmitter systems disrupted by chronic alcohol consumption, particularly glutamatergic hyperactivity, thereby reducing the psychological distress associated with alcohol withdrawal and craving. This pharmacological agent is indicated as part of a comprehensive management program that includes psychosocial support. Its delayed-release tablet formulation ensures consistent plasma concentrations, supporting long-term therapy adherence. Clinical trials and post-marketing surveillance have established its efficacy and safety profile in diverse patient populations.
Accufine: Precision-Engineered Relief for Chronic Neuropathic Pain
Accufine represents a significant advancement in the pharmacological management of moderate to severe chronic neuropathic pain. This prescription medication, containing the active ingredient Pregabalin, is specifically formulated to modulate hyperexcited neurons, providing targeted relief where traditional analgesics often fall short. Its development is grounded in robust clinical research, offering a reliable option for clinicians seeking to improve quality of life for patients suffering from debilitating nerve pain conditions. By specifically targeting the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, Accufine reduces the release of several neurotransmitters, thereby diminishing pain signals and associated symptoms.
Accupril: Effective Blood Pressure Control for Cardiovascular Health
Accupril (quinapril hydrochloride) is an angiotensin-converting enzyme (ACE) inhibitor prescription medication specifically formulated for the management of hypertension and heart failure. As a trusted therapeutic option in cardiovascular medicine, it works by relaxing blood vessels to allow blood to flow more smoothly, thereby reducing the heart’s workload. This medication represents a cornerstone treatment in modern cardiology practice, offering both efficacy and a well-established safety profile when administered under proper medical supervision.